RECK-mediated suppression of tumor cell invasion is regulated by glycosylation in human tumor cell lines

Siro Simizu, Satoshi Takagi, Yuki Tamura, Hiroyuki Osada

Research output: Contribution to journalArticlepeer-review

54 Citations (Scopus)


RECK, a glycosylphosphatidylinositol (GPI)-anchored glycoprotein, negatively regulates matrix metalloproteinases (MMP), such as MMP-9, and inhibits tumor invasion and metastasis. The predicted amino acid sequence of human RECK includes five putative N-glycosylation sites; however, the precise biochemical role of glycosylated RECK remains unknown. In this study, we examined the link between glycosylation and the function of RECK in human tumor cell lines. RECK protein was glycosylated at Asn86, Asn 200, Asn297, and Asn352 residues but not at the Asn39 residue in HT1080 cells. Although the glycosylation of these asparagine sites did not play a role in the cell surface localization of RECK as a GPI-anchored protein, the glycosylation of RECK Asn297 residue was involved in the suppression of MMP-9 secretion and Asn352 residue was necessary to inhibit MMP-2 activation. Moreover, RECK-suppressed tumor cell invasion was reversed by inhibiting glycosylation at Asn86, Asn 297, and Asn352 residues of RECK. Thus, these findings indicate that glycosylation mediates RECK suppression of tumor cell invasion by multiple mechanisms such as suppressing MMP-9 secretion and inhibiting MMP-2 activation.

Original languageEnglish
Pages (from-to)7455-7461
Number of pages7
JournalCancer Research
Issue number16
Publication statusPublished - 2005 Aug 15
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'RECK-mediated suppression of tumor cell invasion is regulated by glycosylation in human tumor cell lines'. Together they form a unique fingerprint.

Cite this